201 related articles for article (PubMed ID: 4555715)
1. Fibrinolytic enhancement by stanozolol: a double blind trial.
Davidson JF; Lochhead M; McDonald GA; McNicol GP
Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
[No Abstract] [Full Text] [Related]
2. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.
Belch JJ; Madhok R; McArdle B; McLaughlin K; Kluft C; Forbes CD; Sturrock RD
Q J Med; 1986 Jan; 58(225):19-27. PubMed ID: 3517926
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic enhancement by stanozolol--a two year study.
Davidson JF; McDonald GA; Conkie JA
Br J Haematol; 1972 May; 22(5):639-40. PubMed ID: 5032111
[No Abstract] [Full Text] [Related]
4. [New trends in the treatment of trophic sequelae post-phlebitic syndrome].
Agus GB; Sarcina A; Lorenzi G; Gabrielli L; Tantalo V
Minerva Med; 1981 Oct; 72(42):2805-8. PubMed ID: 7031512
[TBL] [Abstract][Full Text] [Related]
5. Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults.
Kluft C; Preston FE; Malia RG; Bertina RM; Wijngaards G; Greaves M; Verheijen JH; Dooijewaard G
Thromb Haemost; 1984 Apr; 51(2):157-64. PubMed ID: 6740547
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic enhancement by stanozolol: a double-blind trial.
Davidson JF; McDonald GA; McNicol GP
J Clin Pathol; 1972 Jul; 25(7):639. PubMed ID: 4560843
[No Abstract] [Full Text] [Related]
8. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
9. [Urokinase "Green Cross", a new urokinase preparation. II. In vivo studies].
Fischer M; Pilgerstorfer HW
Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):142-9. PubMed ID: 4895445
[No Abstract] [Full Text] [Related]
10. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
Helle I
Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
[No Abstract] [Full Text] [Related]
12. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery.
Blamey SL; McArdle BM; Burns P; Carter DC; Lowe GD; Forbes CD
Thromb Haemost; 1984 Feb; 51(1):71-4. PubMed ID: 6539002
[TBL] [Abstract][Full Text] [Related]
13. Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.
Jin L; Jin H; Zhang G; Xu G
Clin Hemorheol Microcirc; 2000; 23(2-4):213-8. PubMed ID: 11321442
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation, fibrinolysis, and contraceptive hormones.
Brakman P; Albrechtsen OK; Astrup T
JAMA; 1967 Jan; 199(2):69-74. PubMed ID: 6071154
[No Abstract] [Full Text] [Related]
15. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
Herold R; Straub PW
J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
[No Abstract] [Full Text] [Related]
16. Plasma fibrinolytic activity following oral anabolic steroid therapy.
Walker ID; Davidson JF; Young P; Conkie JA
Thromb Diath Haemorrh; 1975 Sep; 34(1):236-45. PubMed ID: 1103357
[TBL] [Abstract][Full Text] [Related]
17. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
Hedlin AM; Monkhouse FC
Obstet Gynecol; 1971 Feb; 37(2):225-32. PubMed ID: 5539358
[No Abstract] [Full Text] [Related]
18. [Effect of diets with a varying protein content on fibrinolysis in ischemic heart disease].
Andreenko GV; Samsonov MA; Paramonova EG; Karabasova MA
Vopr Pitan; 1978; (5):51-6. PubMed ID: 362708
[TBL] [Abstract][Full Text] [Related]
19. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
Menon IS
Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
[No Abstract] [Full Text] [Related]
20. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
Bielawiec M; Lukjan H; Myśliwiec M; Dabrowski S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
